Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Weak
Telephone
1.833.462.8482
Address
Suite 220 28159 Avenue Stanford Valencia, CA 91355
Description
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.33 - 4.52
Trade Value (12mth)
AU$209,294.00
1 week
-3.6%
1 month
-21.18%
YTD
-67.87%
1 year
-50.19%
All time high
104.14
EPS 3 yr Growth
130.50%
EBITDA Margin
-86.20%
Operating Cashflow
-$74m
Free Cash Flow Return
-69.70%
ROIC
-88.10%
Interest Coverage
-10.30
Quick Ratio
2.50
Shares on Issue (Fully Dilluted)
132m
HALO Sector
Healthcare
Next Company Report Date
19-Feb-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.34
Date | Announcements |
---|---|
03 September 25 |
Notification of cessation of securities - AVH
×
Notification of cessation of securities - AVH |
27 August 25 |
Appendix 3Y and correction to notifiable interests - RM
×
Appendix 3Y and correction to notifiable interests - RM |
26 August 25 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
26 August 25 |
Notice under section 708A(5)(e) of the Corporations Act
×
Notice under section 708A(5)(e) of the Corporations Act |
22 August 25 |
September Investor Conference Participation
×
September Investor Conference Participation |
20 August 25 |
Notice under section 708A(5)(e) of the Corporations Act
×
Notice under section 708A(5)(e) of the Corporations Act |
20 August 25 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
19 August 25 |
Application for quotation of securities - AVH
×
Application for quotation of securities - AVH |
15 August 25 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
15 August 25 |
Notice under section 708A(5)(e) of the Corporations Act
×
Notice under section 708A(5)(e) of the Corporations Act |
14 August 25 |
AVITA Medical Webinar Presentation
×
AVITA Medical Webinar Presentation |
13 August 25 |
AVITA Medical Successfully Completes Australian Equity Raise
×
AVITA Medical Successfully Completes Australian Equity Raise |
13 August 25 |
Proposed issue of securities - AVH
×
Proposed issue of securities - AVH |
11 August 25 |
AVITA Medical to Host Investor Webinar Briefing
×
AVITA Medical to Host Investor Webinar Briefing |
08 August 25 |
AVITA second quarter 2025 financial and business update
×
AVITA second quarter 2025 financial and business update |
08 August 25 |
AVITA Medical second quarter earnings presentation
×
AVITA Medical second quarter earnings presentation |
08 August 25 |
Financial Results for Quarter Ending 30 June 2025
×
Financial Results for Quarter Ending 30 June 2025 |
08 August 25 |
AVITA 10Q Quarterly Report for Q2 2025
×
AVITA 10Q Quarterly Report for Q2 2025 |
08 August 25 |
AVITA (AVH) Appendix 4D for H1 2025
×
AVITA (AVH) Appendix 4D for H1 2025 |
07 August 25 |
Statement of CDIs on issue - AVH
×
Statement of CDIs on issue - AVH |
07 August 25 |
Notification of cessation of securities - AVH
×
Notification of cessation of securities - AVH |
07 August 25 |
Appointment of Director and Transition of Board Chair Role
×
Appointment of Director and Transition of Board Chair Role |
07 August 25 |
Initial Director's Interest Notice - MT
×
Initial Director's Interest Notice - MT |
04 August 25 |
Notification of cessation of securities - AVH
×
Notification of cessation of securities - AVH |
01 August 25 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.